CompanyDrug

JW Therapeutics Secures NMPA Review for CAR-T Therapy in Mantle Cell Lymphoma

HospitalPolicy / Regulatory

China’s Ministry of Education Launches Professional Guidelines for Healthcare Talent Training

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances Novel Cancer Therapies with NMPA Clinical Trial Approval

CompanyDeals

Suzhou Elite Analytical Instruments Secures Over $14 Million in Initial Funding Round

CompanyDrug

Jiangsu Vcare PharmaTech Submits NDA to US FDA for Vicagrel, a P2Y12 Receptor Antagonist

CompanyDeals

Allorion Therapeutics and Avenzo Seal Deal for Global Rights to CDK2 Inhibitor

CompanyDrug

BMS’s Sotyktu, First TYK2 Inhibitor, Hits Chinese Market

Legal / IP

China’s National People’s Congress Approves Stricter Punishments for Sector-Specific Bribery

CompanyDeals

Daiichi Sankyo and Esperion Therapeutics Amend Collaboration on Antilipidemic Drugs

CompanyDrug

Shanghai BDgene Technology’s Thalassemia Gene Therapy BD211 Clears NMPA for Clinical Trials

CompanyDrug

Belief BioMed Group Initiates Clinical Study for Hemophilia A Gene Therapy BBM-H803 in China

CompanyDeals

IASO Biotherapeutics and Umoja Biopharma Join Forces for Innovative Cell and Gene Therapies Development